A detailed history of Pnc Financial Services Group, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 2,032 shares of LGND stock, worth $230,388. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,032
Previous 2,046 0.68%
Holding current value
$230,388
Previous $172,000 18.02%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$82.7 - $110.11 $1,157 - $1,541
-14 Reduced 0.68%
2,032 $203,000
Q2 2024

Aug 09, 2024

SELL
$68.53 - $87.91 $11,307 - $14,505
-165 Reduced 7.46%
2,046 $172,000
Q1 2024

May 10, 2024

BUY
$68.64 - $89.2 $25,465 - $33,093
371 Added 20.16%
2,211 $161,000
Q4 2023

Feb 09, 2024

BUY
$49.57 - $72.63 $22,306 - $32,683
450 Added 32.37%
1,840 $131,000
Q3 2023

Nov 13, 2023

SELL
$58.86 - $72.67 $9,123 - $11,263
-155 Reduced 10.03%
1,390 $83,000
Q2 2023

Aug 11, 2023

SELL
$69.53 - $79.33 $1,390 - $1,586
-20 Reduced 1.28%
1,545 $111,000
Q1 2023

May 15, 2023

BUY
$65.67 - $77.08 $8,537 - $10,020
130 Added 9.06%
1,565 $115,000
Q4 2022

Feb 10, 2023

BUY
$61.72 - $96.74 $10,183 - $15,962
165 Added 12.99%
1,435 $95,000
Q3 2022

Nov 10, 2022

BUY
$0.01 - $107.56 $3 - $42,486
395 Added 45.14%
1,270 $109,000
Q2 2022

Aug 12, 2022

SELL
$74.52 - $117.06 $24,815 - $38,980
-333 Reduced 27.57%
875 $78,000
Q1 2022

May 12, 2022

BUY
$94.99 - $151.56 $7,029 - $11,215
74 Added 6.53%
1,208 $135,000
Q4 2021

Feb 11, 2022

BUY
$127.69 - $165.85 $15,961 - $20,731
125 Added 12.39%
1,134 $175,000
Q3 2021

Nov 05, 2021

BUY
$102.33 - $144.73 $38,271 - $54,129
374 Added 58.9%
1,009 $140,000
Q2 2021

Aug 06, 2021

SELL
$113.03 - $155.64 $2,712 - $3,735
-24 Reduced 3.64%
635 $83,000
Q1 2021

May 07, 2021

BUY
$99.52 - $215.83 $6,667 - $14,460
67 Added 11.32%
659 $100,000
Q4 2020

Feb 12, 2021

SELL
$80.55 - $106.05 $19,815 - $26,088
-246 Reduced 29.36%
592 $58,000
Q3 2020

Nov 06, 2020

SELL
$89.56 - $126.72 $8,956 - $12,672
-100 Reduced 10.66%
838 $79,000
Q2 2020

Aug 07, 2020

SELL
$68.28 - $123.65 $9,968 - $18,052
-146 Reduced 13.47%
938 $104,000
Q1 2020

May 08, 2020

SELL
$63.37 - $107.88 $10,392 - $17,692
-164 Reduced 13.14%
1,084 $78,000
Q4 2019

Feb 07, 2020

BUY
$96.94 - $113.59 $15,413 - $18,060
159 Added 14.6%
1,248 $130,000
Q3 2019

Nov 08, 2019

SELL
$86.25 - $120.16 $98,583 - $137,342
-1,143 Reduced 51.21%
1,089 $108,000
Q2 2019

Aug 09, 2019

BUY
$107.38 - $129.34 $28,133 - $33,887
262 Added 13.3%
2,232 $0
Q1 2019

May 10, 2019

BUY
$105.93 - $142.47 $3,283 - $4,416
31 Added 1.6%
1,970 $0
Q4 2018

Feb 08, 2019

SELL
$128.36 - $272.13 $3.53 Million - $7.48 Million
-27,500 Reduced 93.41%
1,939 $263,000
Q3 2018

Nov 09, 2018

SELL
$211.18 - $274.49 $2.14 Million - $2.78 Million
-10,144 Reduced 25.63%
29,439 $0
Q2 2018

Aug 10, 2018

BUY
$150.77 - $207.98 $8,895 - $12,270
59 Added 0.15%
39,583 $0
Q1 2018

May 11, 2018

SELL
$138.63 - $182.62 $25,092 - $33,054
-181 Reduced 0.46%
39,524 $0
Q4 2017

Feb 09, 2018

BUY
$128.36 - $147.04 $1.6 Million - $1.83 Million
12,440 Added 45.63%
39,705 $0
Q3 2017

Nov 13, 2017

BUY
$120.91 - $137.94 $3.3 Million - $3.76 Million
27,265
27,265 $0

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.91B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.